Benzinga's Top Initiations - Cidara Therapeutics (NASDAQ:CDTX)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Analysts at Bank of America initiated coverage on Aduro BioTech Inc

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

(NASDAQ: ADRO) with a Buy rating. The target price for Aduro Biotech is set to $40. Aduro Biotech shares closed at $30.85 on Friday.Analysts at Evercore Partners initiated coverage on Virtu Financial Inc (NASDAQ: VIRT) with a Buy rating. The target price for Virtu Financial is set to $25. Virtu Financial shares closed at $22.30 on Friday.Analysts at Oppenheimer initiated coverage on Godaddy Inc (NYSE: GDDY) with a Outperform rating. The target price for Godaddy is set to $31. Godaddy shares closed at $24.88 on Friday.RBC Capital initiated coverage on KemPharm Inc (NASDAQ: KMPH) with a Outperform rating. The target price for KemPharm is set to $18. KemPharm shares closed at $12.05 on Friday.Analysts at Deutsche Bank initiated coverage on Wix.Com Ltd

Want Private Access to Benzinga Analyst?

Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.

(NASDAQ: WIX) with a Hold rating. The target price for Wix.com is set to $25. Wix.com shares closed at $23.75 on Friday.Deutsche Bank initiated coverage on

Endurance International Group Hldgs Inc (NASDAQ: EIGI) with a Hold rating. The target price for Endurance International Group is set to $19. Endurance International Group shares closed at $20.96 on Friday.Analysts at Guggenheim Securities initiated coverage on Paratek Pharmaceuticals Inc (NASDAQ: PRTK) with a Buy rating. The target price for Paratek Pharmaceuticals is set to $37. Paratek Pharmaceuticals' shares closed at $26.56 on Friday.RBC Capital initiates coverage on Godaddy Inc (NYSE: GDDY) with a Outperform rating. The target price for Godaddy is set to $30. Godaddy shares closed at $24.88 on Friday.Analysts at Guggenheim Securities initiated coverage on Egalet Corp (NASDAQ: EGLT) with a Buy rating. The target price for Egalet is set to $24. Egalet shares closed at $9.10 on Friday.Wedbush initiated coverage on Cidara Therapeutics Inc (NASDAQ: CDTX) with a Outperform rating. The target price for Cidara Therapeutics is set to $22. Cidara Therapeutics shares closed at $14.94 on Friday.